[Combined therapy of interstitial cystitis using the "Aeltis-Synchro-02-Iarilo" device].
Multiple modality therapy of interstitial cystitis (IC)--the disease characterized by nicturia, pelvic pains, imperative pollakiuria--is considered. As IC nature is not well known, its treatment remains empiric. Among the underlying causes, most probable are autoimmune, allergic, infectious, neurological, vascular. Therefore, the treatment should be multi-modality. Most usable now is combined chemotherapy. Perspective is also IC treatment with medicines in combination with physiotherapy (electromagnetolaser AELTIS-SYNCHRO-02-YARILO"). Endovesical electrophoresis can be also applied.
Kalinina
S N
SN
Molchanov
A V
AV
Rutskaia
N S
NS
D000328:Adult; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018856:Cystitis, Interstitial / Q000188:drug therapy* / Q000532:radiotherapy*; D004566:Electrodes; D004867:Equipment Design; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007478:Iontophoresis; D028022:Low-Level Light Therapy / Q000295:instrumentation / Q000379:methods; D008875:Middle Aged; D016896:Treatment Outcome; D014563:Urodynamics
D000779:Anesthetics, Local; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists